FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23615111000001106: Nevirapine 200mg tablets (Creo Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 08-Jan 2014. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
77135701000001115 Nevirapine 200mg tablets (Creo Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
77135801000001112 Nevirapine 200mg tablets (Creo Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Nevirapine 200mg tablets (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) Is a Product containing precisely nevirapine 200 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) Has active ingredient Nevirapine false Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) Has specific active ingredient Nevirapine true Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Nevirapine 200mg tablets (Creo Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Nevirapine 200mg tablets (Creo Pharma Ltd) 60 tablet Has AMP True Nevirapine 200mg tablets (Creo Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start